EU_TED process · buyer country ESP · award
Suministro de medicamento exclusivo Blinatumomab 38,5 microgramos inyectable (Blincyto 38,5 mcg)
['Hospital Infantil Universitario Niño Jesús']
EUR 115,385
Data last updated Oct 22, 2026 · Source: Tenders Electronic Daily
- Buyer identifier
- TED_ORGANISATION: Q2877003J
- Primary supplier
- ['AMGEN, S.A.']
- Procurement method
- Not reported
- Tender deadline
- Not reported
- Contract period
- Not reported — Not reported
- Native value
- EUR 115,385
- USD comparison
- Not shown — no auditable FX observation
- Official source
- Open notice ↗
Description
Suministro de medicamento exclusivo Blinatumomab 38,5 microgramos inyectable (Blincyto 38,5 mcg)
Suppliers
- ['AMGEN, S.A.'] · primary
Official lifecycle
Process timeline
- Award announced
Suministro de medicamento exclusivo Blinatumomab 38,5 microgramos inyectable (Blincyto 38,5 mcg)
Notice versions
| Publication | Version | Type | Date | Source |
|---|---|---|---|---|
| 755656-2026 | 1 | can-standard | Oct 30, 2026 | Official notice ↗ · XML ↗ |
Lots
| Lot | CPV | Performance | NUTS | Value |
|---|---|---|---|---|
| LOT-0001 | 33600000, 33600000 | ESP | ES300 | Not reported |
Contracts
| Contract | Lot | Status | Period | Value |
|---|---|---|---|---|
| A/SUM-017062/2026C01 | LOT-0001 | Not reported | Not reported — Not reported | Not reported |
Auditable model output
Predictive intelligence
Append-only source history
Source records
| Record | Date | Stages | Fetched |
|---|---|---|---|
| 34eb299f-e354-41a5-ac3a-b31ecc0cb2fb:1 | Oct 30, 2026 | award_announced | Oct 31, 2026 |